[ad_1]
Preliminary results of a mixed Phase 1 and a couple of trial of a coronavirus vaccine developed by the University of Oxford recommend that’s protected and induces an immune response, in line with a launch from the medical journal The Lancet. CNN’s Anna Stewart reviews.
[ad_2]
Source link